Pandemic superstar fund, ARKK Innovation ETF, has been facing tremendous pressure as its stock continues to dip. Economic conditions and the losses recorded by its holdings have contributed to its woes. We believe buying the dip on ARKK is not wise at this time.
Some popular names in the healthcare sector have been down even by about 50% from their highs recently. But there are lots of opportunities in this sector.
There may be no greater advantage than being a first mover, so here are a couple that are still way down off of their recent 52-week and all-time highs.